Can Too Much Be Bad: Aggressively Lowering LDL Not Associated with Improvement in Maximal Intimal Thickening

Statins are the only Class I ISHLT recommendation in heart transplantation (HT) as an established therapy to reduce cardiac allograft vasculopathy (CAV) and improve survival. However, the goal LDL is not known with no formal recommendation on targets. We assessed if LDL

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: R. Lee, E.J. Henricksen, Y. Moayedi, K. Runeckles, C.S. Fan, J. Han, K.Y. Feng, W. Yang, K. Town, P. Marks, J.W. MacArthur, K.K. Khush, J.J. Teuteberg Tags: (553) Source Type: research